Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes
Sandrine Levet, Julie Medina, Julie Joanou, Amandine Demolder, Nelly Queruel, Kevin Réant, Matthieu Normand, Marine Seffals, Julie Dimier, Raphaële Germi, Thomas Piofczyk, Jacques Portoukalian, Jean-Louis Touraine, Hervé Perron
Sandrine Levet, Julie Medina, Julie Joanou, Amandine Demolder, Nelly Queruel, Kevin Réant, Matthieu Normand, Marine Seffals, Julie Dimier, Raphaële Germi, Thomas Piofczyk, Jacques Portoukalian, Jean-Louis Touraine, Hervé Perron
View: Text | PDF
Research Article Endocrinology

An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes

  • Text
  • PDF
Abstract

Human endogenous retroviruses (HERVs), remnants of ancestral viral genomic insertions, are known to represent 8% of the human genome and are associated with several pathologies. In particular, the envelope protein of HERV-W family (HERV-W-Env) has been involved in multiple sclerosis pathogenesis. Investigations to detect HERV-W-Env in a few other autoimmune diseases were negative, except in type-1 diabetes (T1D). In patients suffering from T1D, HERV-W-Env protein was detected in 70% of sera, and its corresponding RNA was detected in 57% of peripheral blood mononuclear cells. While studies on human Langerhans islets evidenced the inhibition of insulin secretion by HERV-W-Env, this endogenous protein was found to be expressed by acinar cells in 75% of human T1D pancreata. An extensive immunohistological analysis further revealed a significant correlation between HERV-W-Env expression and macrophage infiltrates in the exocrine part of human pancreata. Such findings were corroborated by in vivo studies on transgenic mice expressing HERV-W-env gene, which displayed hyperglycemia and decreased levels of insulin, along with immune cell infiltrates in their pancreas. Altogether, these results strongly suggest an involvement of HERV-W-Env in T1D pathogenesis. They also provide potentially novel therapeutic perspectives, since unveiling a pathogenic target in T1D.

Authors

Sandrine Levet, Julie Medina, Julie Joanou, Amandine Demolder, Nelly Queruel, Kevin Réant, Matthieu Normand, Marine Seffals, Julie Dimier, Raphaële Germi, Thomas Piofczyk, Jacques Portoukalian, Jean-Louis Touraine, Hervé Perron

×

Figure 4

Transgenic mice expressing HERV-W-env display hyperglycemia and pancreatic abnormalities.

Options: View larger image (or click on image) Download as PowerPoint
Transgenic mice expressing HERV-W-env display hyperglycemia and pancreat...
(A and B) Seven-week-old CAG-Env transgenic mice expressing of HERV-W-env and control C57Bl/6J mice of the same age were fasted for 5 hours before measuring glycemia (A) and insulinemia (B). Results are presented as individual values and as mean ± SEM. n = 10 or 11 mice in each group. Significance determined by unpaired t test (glycemia) or by Mann-Whitney U test, one-tailed (insulinemia). (C) Pancreas sections of 12-month-old CAG-Env mice (n = 5 females and n = 6 males) and C57BL/6J mice (n = 5 females and n = 7 males) were stained with HES (Hematoxylin Eosin Saffran). Representative images of C57BL/6J (left panels) and CAG-Env (right panels) mouse pancreata were presented at 10× (upper panels) and 40× (lower panels) original magnification. Fatty infiltrates are highlighted with green arrows and immune cells infiltrates with orange arrows. Scale bars: upper panels, 200 μm; lower panels, 50 μm. (D and E) Pancreas sections from 12-month-old CAG-Env mice (n = 5 females and n = 6 males) and C57BL/6J mice (n = 5 females and n = 7 males) were analyzed for immune cell infiltration (D) and fat infiltration (E). A gradation from 0–3 was affected to each slide, 0 corresponding to no infiltration of fat or immune cells and 3 corresponding to high level of infiltrations. Two sections distant by 500 μm were analyzed for each mouse, blindly and independently by 2 people, and their evaluations were averaged for each slide. Results are presented as mean of the 2 slides for each mouse and as mean ± SEM for each group. Significance was determined by Mann Whitney U test. *P < 0.05; **P < 0.01, ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts